Condition
Nonalcoholic Steatohepatitis clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Nonalcoholic Steatohepatitis clinical trials that are recruiting, at sites in 2 countries (most in United States (4), China (2)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Nonalcoholic Steatohepatitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tesamorelin to reduce liver fat in adults with fatty liver disease | Phase 2 | Shenzhen, Guangdong | Recruiting | Mar 19, 2026 |
| Monitoring liver health in patients with Nonalcoholic Steatohepatitis and cirrhosis | — | Rochester, Minnesota and 1 other locations | Recruiting | Feb 9, 2023 |
| Using thyroid hormone to treat liver disease in veterans | Phase 2 | Columbia, Missouri | Recruiting | Sep 2, 2022 |
| Assessing liver fat levels in HIV/AIDS patients on different medications | — | Beijing, Beijing Municipality | Recruiting | Apr 15, 2022 |
| Understanding how obesity affects insulin resistance through diet and molecular profiling | — | Stanford, California | Recruiting | Dec 21, 2021 |
| Low-dose pioglitazone for treating liver disease in diabetes patients | Phase 2 | Gainesville, Florida | Recruiting | Aug 6, 2020 |
All recruiting trials (6)
-
Tesamorelin to reduce liver fat in adults with fatty liver disease
This trial tests whether a daily self‑injection of tesamorelin can lower liver fat over 52 weeks in adults with fatty liver disease.
-
Monitoring liver health in patients with Nonalcoholic Steatohepatitis and cirrhosis
This study is testing new ways to monitor liver health in people with Nonalcoholic Steatohepatitis and cirrhosis to see if they can better predict complications and improve care.
-
Using thyroid hormone to treat liver disease in veterans
This study is testing if low doses of thyroid hormone can help veterans with liver disease called NASH feel better and improve their liver health.
-
Assessing liver fat levels in HIV/AIDS patients on different medications
This study is trying to see how different HIV medications affect liver fat levels in patients living with HIV/AIDS to understand the risk of liver disease.
-
Understanding how obesity affects insulin resistance through diet and molecular profiling
This study is trying to see how different diets can affect insulin resistance in people with obesity by looking at changes in their body and blood over 12 weeks.
-
Low-dose pioglitazone for treating liver disease in diabetes patients
This study is testing if a low dose of pioglitazone can improve liver health in people with type 2 diabetes and a specific liver condition called NASH.
Related topics
Quick answers
How many Nonalcoholic Steatohepatitis clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.